Catalyst Biosciences Reports Second Quarter 2016 Financial Results and Provides Corporate Update

Go back to Catalyst Biosciences Reports Second Quarter 2016 Financial Results and Provides Corporate Update

Catalyst Biosciences (CBIO) Reports Q2 Loss of $0.42/Share

August 4, 2016 8:40 AM EDT

Catalyst Biosciences (NASDAQ: CBIO) reported Q2 EPS of ($0.42), versus ($4.60) reported last year.

For earnings history and earnings-related data on Catalyst Biosciences (CBIO) click here.

... More